RÉSUMÉ
AIMS: The genic male sterility (GMS) system is an important strategy for generating heterosis in plants. To better understand the essential role of lipid and sugar metabolism and to identify additional candidates for pollen development and male sterility, transcriptome and metabolome analysis of a GMS line of 1205AB in B. napus was used as a case study. DATA RESOURCES GENERATED: To characterize the GMS system, the transcriptome and metabolome profiles were generated for 24 samples and 48 samples of 1205AB in B. napus, respectively. Transcriptome analysis yielded a total of 156.52 Gb of clean data and revealed the expression levels of 109,541 genes and 8,501 novel genes. In addition, a total of 1,353 metabolites were detected in the metabolomic analysis, including 784 in positive ion mode and 569 in negative ion mode. KEY RESULTS: A total of 15,635 differentially expressed genes (DEGs) and 83 differential metabolites (DMs) were identified from different comparison groups, most of which were involved in lipid and sugar metabolism. The combination of transcriptome and metabolome analysis revealed 49 orthologous GMS genes related to lipid metabolism and 46 orthologous GMS genes related to sugar metabolism, as well as 45 novel genes. UTILITY OF THE RESOURCE: The transcriptome and metabolome profiles and their analysis provide useful reference data for the future discovery of additional GMS genes and the development of more robust male sterility breeding systems for use in the production of plant hybrids.
Sujet(s)
Brassica napus , Régulation de l'expression des gènes végétaux , Métabolisme lipidique , Stérilité des plantes , Pollen , Transcriptome , Pollen/génétique , Pollen/croissance et développement , Pollen/physiologie , Pollen/métabolisme , Stérilité des plantes/génétique , Stérilité des plantes/physiologie , Brassica napus/génétique , Brassica napus/physiologie , Brassica napus/croissance et développement , Brassica napus/métabolisme , Métabolisme lipidique/génétique , Transcriptome/génétique , Métabolome/génétique , Métabolisme glucidique/génétique , Analyse de profil d'expression de gènes , Sucres/métabolismeRÉSUMÉ
OBJECTIVE: To explore the effect of traditional Chinese medicine (TCM) on the treatment of chronic kidney disease (CKD). METHODS: Databases were used for literature research until 16 December 2022, including PubMed, Cochrane Library, China National Knowledge Infrastructure (CNKI), and Embase. After full-text screening, data were extracted by two researchers independently. The Cochrane ROB tool was applied for quality assessment. The heterogeneity was tested using the Chi-squared-based Q statistic test and the I2 statistic. RESULTS: The findings revealed that the use of TCM significantly improved the total effective rate (pooled odds ratio (OR) = 1.35, 95% confidence interval (CI) = [1.15, 1.57]), reduced the serum creatinine (SCr) level (pooled mean difference (MD) = -0.11, 95% CI = [-0.20, -0.03]), and increased the estimated glomerular filtration rate (eGFR, pooled MD = 3.76, 95% CI = [2.66, 4.87]) in patients with CKD, compared with non-TCM treatment. Meanwhile, TCM performed better effect on 24-h proteinuria (pooled MD = 0.17, 95% CI = [0.04, 0.31]) than non-TCM. No significant difference in the incidence of adverse events was found between TCM and non-TCM treatment (pooled OR = 0.63, 95% CI = [0.32, 1.24]). Sensitivity analysis demonstrated the stability of the pooled estimates. CONCLUSION: TCM has the advantage over non-TCM treatment and is worth popularizing and applying in the prevention and cure of CKD. PROSPERO REGISTRATION NUMBER: CRD42021279281.
Sujet(s)
Médecine traditionnelle chinoise , Insuffisance rénale chronique , Humains , Créatinine/sang , Médicaments issus de plantes chinoises/administration et posologie , Débit de filtration glomérulaire , Médecine traditionnelle chinoise/méthodes , Protéinurie , Insuffisance rénale chronique/physiopathologie , Insuffisance rénale chronique/thérapie , Résultat thérapeutiqueRÉSUMÉ
Herein, by applying visible-light photoredox catalysis, we have now achieved the first example of catalytic dehydrogenative coupling of phosphines and thiophenols that proceeds at room temperature. Key to our success is the use of benzaldehyde as a soft oxidant, which avoids the issue of phosphine oxidation. Furthermore, we observed the unexpected dealkylative coupling of secondary and tertiary alkylphosphine with thiophenols.